title: Rapid Resolution of Graft-versus-Host-Disease-Related Central Serous Chorioretinopathy.
abstract: We present a 23-year-old female patient who developed bilateral, multifocal CSCR three months after BMT and two months after developing GvHD. At the time of diagnosis, her medications included cyclosporine and high-dose oral steroid for GvHD. CSCR resolved quickly after the resolution of GvHD, along with rapid tapering of steroids and restoration of emotional wellbeing. Rapid tapering of systemic steroids under close monitoring of a hematologist in the setting of resolved mild GvHD may facilitate prompt resolution of CSCR.
authors: a South Australian Institute of Ophthalmology, Royal Adelaide Hospital , Adelaide , South Australia.
authors: Soo Khai
authors: SK
authors: Ng
authors: a South Australian Institute of Ophthalmology, Royal Adelaide Hospital , Adelaide , South Australia.
authors: Shane
authors: S
authors: Durkin
authors: a South Australian Institute of Ophthalmology, Royal Adelaide Hospital , Adelaide , South Australia.
authors: Jagjit S
authors: JS
authors: Gilhotra
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D056833:Central Serous Chorioretinopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016572:Cyclosporine / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D005076:Exanthema / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016572:Cyclosporine
keywords: Bone marrow transplant; central serous chorioretinopathy; cortiscosteroid; graft versus host disease